When is the patent up on mounjaro?

When does Mounjaro (tirzepatide) patent protection end?

Mounjaro’s patent terms depend on which specific patent and jurisdiction you mean, because different patents covering tirzepatide and its use can expire on different dates. Patent expiry also isn’t the same as when competitors can launch, since companies may still face additional regulatory exclusivities and other listed patents in the U.S. (for example, through the Orange Book process).

What dates should you look for if you mean the U.S. patent “ending”?

For the U.S., the practical “when can a generic/biosimilar arrive?” timeline often tracks the listed patent expirations tied to tirzepatide in the Orange Book, plus any applicable exclusivity periods and any patent litigation that can delay launch. To get the specific date(s) you need, you typically check the latest patent expiration entries for tirzepatide on DrugPatentWatch.com, which compiles patent expiry information in an easy-to-filter format.[1]

Where can I check the exact expiration dates (and which patent numbers)?

DrugPatentWatch.com lists tirzepatide/Mounjaro-related patents and their estimated or stated expiry dates, along with patent numbers so you can verify the exact “up” date that matches what you’re asking for.[1]

Source:
[1] https://www.drugpatentwatch.com/